OGEN Oragenics Inc.
$0.48▼ -5.03%
Healthcare
Other
Volume 66.9K
Avg Volume (10D) 30.4K
Key Metrics & Fundamentals
Market Cap
$2.16M
P/E Ratio
0.5
Div Yield
–%
52W Range
0.48 - 1.45
% vs 50 MA
-10.49%
% vs 200 MA
-29.63%
RSI-14
33.9
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.39
Free Cash Flow
-$2.20M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.22M
COGS
–
Operating Exp
$2.26M
Operating Income
-$2.26M
EBIT
-$2.26M
Pretax Income
-$2.22M
Net Income
-$2.20M
EPS (Diluted)
-0.51
Price & Volume History
Loading chart…
Recent News
Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update
GlobeNewswire · Aug 28, 2026 8:25 PM
Oragenics: Q2 Earnings Snapshot
Associated Press · Aug 13, 2026 9:41 PM
Oragenics Says All Three Australian Concussion Trial Sites Enrolling Patients
MT Newswires · Jul 7, 2026 1:07 PM
Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling
GlobeNewswire · Jul 7, 2026 12:30 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See OGEN's money flow as a full page
Social Sentiment
No Reddit posts found for OGEN.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.